Time course of changes in the concentration of kynurenic acid in the brain of pentylenetetrazol-kindled rats

Brain Research Bulletin

Volumn 78, Issue 6, 2009, Pages 299-305

  Maciejak, Piotr ^a,b   Szyndler, Janusz ^a   Turzyńska, Danuta ^b   Sobolewska, Alicja ^b   Taracha, Ewa ^b   Skórzewska, Anna ^b   Lehner, Małgorzata ^b   Bidziński, Andrzej ^b   Płaźnik, Adam ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Epilepsy; Kindling; KYNA; PTZ; Rat

Indexed keywords

KYNURENIC ACID; NEUROTRANSMITTER; PENTETRAZOLE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; CONVULSION; ENTORHINAL CORTEX; EPILEPSY; HIPPOCAMPUS; KINDLING; MALE; NEUROSECRETION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; SEIZURE;

ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; KINDLING, NEUROLOGIC; KYNURENIC ACID; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES;

EID: 58949105088     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.10.010     Document Type: Article

References (50)

1. Baran H., Cairns N., Lubec B., and Lubec G. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome. Life Sci. 58 (1996) 1891-1899
2. Baran H., Jellinger K., and Deecke L. Kynurenine metabolism in Alzheimer's disease. J. Neural Transm. 106 (1999) 165-181
3. Cozzi A., Carpenedo R., and Moroni F. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-(N-4-(nitrophenyl)thiazol-2yl)-benzenesulfonamide (Ro 61-8048) in models of focal or global brain ischemia. J. Cereb. Blood Flow Metab. 19 (1999) 771-777
4. Dragunow M., Robertson H.A., and Robertson G.S. Amygdala kindling and c-fos protein(s). Exp. Neurol. 102 (1988) 261-263
5. During M.J., and Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341 (1993) 1607-1610
6. Erhardt S., Blennow K., Nordin C., Skogh E., Lindstrom L.H., and Engberg G. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci. Lett. 313 (2001) 96-98
7. Ferland R.J., Nierenberg J., and Applegate C.D. A role for the bilateral involvement of perirhinal cortex in generalized kindled seizure expression. Exp. Neurol. 151 (1998) 124-137
8. Gramsbergen J.B., Hodgkins P.S., Rassoulpour A., Turski W.A., Guidetti P., and Schwarcz R. Brain-specific modulation of kynurenic acid synthesis in the rat. J. Neurochem. 69 (1997) 290-298
9. Goddard G.V. The development of epileptic seizures through brain stimulation at low intensity. Nature 214 (1967) 1020-1021
10. Guidetti P., Okuno E., and Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J. Neurosci. Res. 50 (1997) 457-465
11. Heyes M.P., Saito K., Devinsky O., and Nadi N.S. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures. Epilepsia 35 (1994) 251-257
12. Hilmas C., Pereira E.F., Alkondon M., Rassoulpour A., Schwarcz R., and Albuquerque E.X. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21 (2001) 7463-7473
13. Hosford D.A., Simonato M., Cao Z., Garcia-Cairasco N., Silver J.M., Butler L., Shin C., and McNamara J.O. Differences in the anatomic distribution of immediate-early gene expression in amygdala and angular bundle kindling development. J. Neurosci. 15 (1995) 2513-2523
14. Kamiński R.M., Zielińska E., Dekundy A., van Luijtelaar G., and Turski W. Deficit of endogenous kynurenic acid in the frontal cortex of rats with a genetic form of absence epilepsy. Pol. J. Pharmacol. 55 (2003) 741-746
15. Kamphuis W., Huisman E., Dreijer A.M., Ghijsen W.E., Verhage M., and Lopes da Silva F.H. Kindling increases the K(+)-evoked Ca2(+)-dependent release of endogenous GABA in area CA1 of rat hippocampus. Brain Res. 511 (1990) 63-70
16. Kapoor R., Okuno E., Kido R., and Kapoor V. Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord. Neuroreport 8 (1997) 3619-3623
17. Kaura S., Bradford H.F., Young A.M., Croucher M.J., and Hughes P.D. Effect of amygdaloid kindling on the content and release of amino acids from the amygdaloid complex: in vivo and in vitro studies. J. Neurochem. 65 (1995) 1240-1249
18. Kessler M., Terramani T., Lynch G., and Baudry M. A glycine site associated with N-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists. J. Neurochem. 52 (1989) 1319-1328
19. Kiss C., Ceresoli-Borroni G., Guidetti P., Zielke C.L., Zielke H.R., and Schwarcz R. Kynurenate production by cultured human astrocytes. J. Neural Transm. 110 (2003) 1-14
20. Kocki T., Kocki J., Wielosz M., Turski W.A., and Urbanska E.M. Carbamazepine enhances brain production of kynurenic acid in vitro. Eur. J. Pharmacol. 498 (2004) 325-326
21. Kocki T., Wielosz M., Turski W.A., and Urbanska E.M. Enhancement of brain kynurenic acid production by anticonvulsants-novel mechanism of antiepileptic activity?. Eur. J. Pharmacol. 541 (2006) 147-151
22. Liebowitz N.R., Pedley T.A., and Cutler R.W. Release of gamma-aminobutyric acid from hippocampal slices of the rat following generalized seizures induced by daily electrical stimulation of entorhinal cortex. Brain Res. 138 (1977) 369-373
23. Löscher W., and Ebert U. The role of the piriform cortex in kindling. Prog. Neurobiol. 50 (1996) 427-481
24. Löscher W., Ebert U., and Lehmann H. Kindling induces a lasting, regionally selective increase of kynurenic acid in the nucleus accumbens. Brain Res. 725 (1996) 252-256
25. Meldrum B.S., Akbar M.T., and Chapman A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res. 36 (1999) 189-204
26. Minamoto Y., Itano T., Tokuda M., Matsui H., Janjua N.A., Hosokawa K., Okada Y., Murakami T.H., Negi T., and Hatase O. In vivo microdialysis of amino acid neurotransmitters in the hippocampus in amygdaloid kindled rat. Brain Res. 573 (1992) 345-348
27. Morimoto K., Fahnestock M., and Racine R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol. 73 (2004) 1-60
28. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites. Eur. J. Pharmacol. 375 (1999) 87-100
29. Nemeth H., Robotka H., Kis Z., Rozsa E., Janaky T., Somlai C., Marosi M., Farkas T., Toldi J., and Vecsei L. Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study. Neuropharmacology 47 (2004) 916-925
30. Nemeth H., Toldi J., and Vecsei L. Role of kynurenines in the central and peripheral nervous systems. Curr. Neurovasc. Res. 2 (2005) 249-260
31. Ogawa T., Matson W.R., Beal M.F., Myers R.H., Bird E.D., Milbury P., and Saso S. Kynurenine pathway abnormalities in Parkinson's disease. Neurology 42 (1992) 1702-1706
32. Racine R.J., Gartner J.G., and Burnham W.M. Epileptiform activity and neural plasticity in limbic structures. Brain Res. 47 (1972) 262-268
33. Ramzan I.M., and Levy G. Kinetics of drug action in disease states. XIV. Effect of infusion rate on pentylenetetrazol concentrations in serum, brain and cerebrospinal fluid of rats at onset of convulsions. J. Pharmacol. Exp. Ther. 234 (1985) 624-628
34. Rozsa E., Robotka H., Nagy D., Farkas T., Sas K., Vecsei L., and Toldi J. The pentylenetetrazole-induced activity in the hippocampus can be inhibited by the conversion of l-kynurenine to kynurenic acid: an in vitro study. Brain Res. Bull. 76 5 (2008) 474-479
35. Sas K., Robotka H., Toldi J., and Vecsei L. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J. Neurol. Sci. 257 (2007) 221-239
36. Sato T., Yamada N., Morimoto K., Uemura S., and Kuroda S. A behavioral and immunohistochemical study on the development of perirhinal cortical kindling: a comparison with other types of limbic kindling. Brain Res. 811 (1998) 122-132
37. Scharfman H.E., and Ofer A. Pretreatment with l-kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined entorhinal/hippocampal slices. Neurosci. Lett. 224 (1997) 115-118
38. Stone T.W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol. 64 (2001) 185-218
39. Takemiya T., Matsumura K., and Yamagata K. Roles of prostaglandin synthesis in excitotoxic brain diseases. Neurochem. Int. 51 2-4 (2007) 112-120
40. Tirassa P., and Costa N. CCK-8 induces NGF and BDNF synthesis and modulates TrkA and TrkB expression in the rat hippocampus and septum: effects on kindling development. Neurochem. Int. 50 1 (2007) 130-138
41. Turski W.A., Nakamura M., Todd W.P., Carpenter B.K., Whetsell Jr. W.O., and Schwarcz R. Identification and quantification of kynurenic acid in human brain tissue. Brain Res. 454 (1988) 164-169
42. Turski W.A., Gramsbergen J.B., Traitler H., and Schwarcz R. Rat brain slices produce and liberate kynurenic acid upon exposure to l-kynurenine. J. Neurochem. 52 (1989) 1629-1636
43. Turski W.A., Urbanska E., Dziki M., Parada-Turska J., and Ikonomidou C. Excitatory amino acid antagonists protect mice against seizures induced by bicuculline. Brain Res. 514 (1990) 131-134
44. Ueda Y., and Tsuru N. Simultaneous monitoring of the seizure-related changes in extracellular glutamate and gamma-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling. Epilepsy Res. 20 (1995) 213-219
45. Ullal G.R., Michalski B., Xu B., Racine R.J., and Fahnestock M. NT-3 modulates BDNF and proBDNF levels in naïve and kindled rat hippocampus. Neurochem. Int. 50 6 (2007) 866-871
46. Urbanska E.M., Kocki T., Saran T., Kleinrok Z., and Turski W.A. Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists. Neuroreport 8 (1997) 3501-3505
47. Wu H.Q., Baran H., Ungerstedt U., and Schwarcz R. Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur. J. Neurosci. 4 (1992) 1264-1270
48. Wu H.Q., Monno A., Schwarcz R., and Vezzani A. Electrical kindling is associated with a lasting increase in the extracellular levels of kynurenic acid in the rat hippocampus. Neurosci. Lett. 198 (1995) 91-94
49. Yamamoto H., Murakami H., Horiguchi K., and Egawa B. Studies on cerebrospinal fluid kynurenic acid concentrations in epileptic children. Brain Dev. 17 (1995) 327-329
50. Yamamoto H., Shindo I., Egawa B., and Horiguchi K. Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms. Pediatr. Neurol. 10 (1994) 9-12